Live Breaking News & Updates on Vistagen Therapeutics Company Profile

Stay updated with breaking news from Vistagen therapeutics company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Vistagen Therapeutics (VTGN) Set to Announce Quarterly Earnings on Tuesday

Vistagen Therapeutics (NASDAQ:VTGN – Get Free Report) will be issuing its quarterly earnings data after the market closes on Tuesday, February 13th. Analysts expect the company to announce earnings of ($0.31) per share for the quarter. Vistagen Therapeutics (NASDAQ:VTGN – Get Free Report) last posted its earnings results on Thursday, November 9th. The company reported […] ....

William Blair , Stifel Nicolaus , Vistagen Therapeutics Company Profile , Mirabella Financial Services , Vistagen Therapeutics Inc , Deutsche Bank , Morgan Stanley , Jefferies Financial Group , Vistagen Therapeutics , Get Free Report , Sigma Advisers , Financial Group , Vistagen Therapeutics Daily , Nasdaq Vtgn ,

Vistagen Therapeutics (NASDAQ:VTGN) Stock Price Crosses Above Fifty Day Moving Average of $4.86

Vistagen Therapeutics (NASDAQ:VTGN) Stock Price Crosses Above Fifty Day Moving Average of $4.86
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Hong Kong , William Blair , Stifel Nicolaus , Vistagen Therapeutics Company Profile , Citadel Advisors , Vistagen Therapeutics Inc , Y Intercept Hong Kong Ltd , Raymond James Associates , Mirabella Financial Services , Jefferies Financial Group , Vistagen Therapeutics , Get Free Report , Financial Group , Therapeutics Trading Down , Financial Services , Intercept Hong Kong Ltd , Jane Street Group , Vistagen Therapeutics Daily ,

Vistagen Therapeutics, Inc. (NASDAQ:VTGN) Sees Large Decrease in Short Interest

Vistagen Therapeutics, Inc. (NASDAQ:VTGN) Sees Large Decrease in Short Interest
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

William Blair , Stifel Nicolaus , Vistagen Therapeutics Company Profile , Jefferies Financial Group , Schonfeld Strategic Advisors , Capital Management , Blair William Co , Raymond James Associates , Vanguard Group Inc , Vistagen Therapeutics Inc , Vistagen Therapeutics , Get Free Report , Financial Group , Strategic Advisors , Vistagen Therapeutics Daily ,

Vistagen Therapeutics (NASDAQ:VTGN) Upgraded by Jefferies Financial Group to "Buy"

Jefferies Financial Group upgraded shares of Vistagen Therapeutics (NASDAQ:VTGN – Free Report) from a hold rating to a buy rating in a research report report published on Thursday morning, Marketbeat reports. They currently have $15.00 price objective on the stock. VTGN has been the topic of a number of other research reports. William Blair restated […] ....

Stifel Nicolaus , William Blair , Maxim Group , Renaissance Technologies , Jefferies Financial Group , Vistagen Therapeutics Company Profile , Blackrock Inc , Vistagen Therapeutics Inc , Vistagen Therapeutics , Free Report , Get Free Report , Street Corp , Sigma Investments , Two Sigma Advisers , Vistagen Therapeutics Daily , Nasdaq Vtgn , Jefferies Financial Group Inc ,

Vistagen Therapeutics (NASDAQ:VTGN) Earns Buy Rating from Analysts at Stifel Nicolaus

Stifel Nicolaus initiated coverage on shares of Vistagen Therapeutics (NASDAQ:VTGN – Free Report) in a research report sent to investors on Tuesday, Benzinga reports. The firm issued a buy rating and a $12.00 price target on the stock. Separately, Maxim Group reiterated a buy rating and issued a $30.00 price target on shares of Vistagen […] ....

Stifel Nicolaus , Maxim Group , Renaissance Technologies , Vistagen Therapeutics Company Profile , Blackrock Inc , Vistagen Therapeutics Inc , Vistagen Therapeutics , Free Report , Street Corp , Sigma Investments , Two Sigma Advisers , Get Free Report , Vistagen Therapeutics Daily , Nasdaq Vtgn , Initiated Coverage ,